Ariane Chan

Ariane has extensive experience working for leading industry and crown-owned companies across the science, research and innovation sectors. After completing a PhD in Biomedical Science from Victoria University of Wellington (anti-cancer drug discovery), Ariane held a number of roles at Volpara Health Technologies Ltd, which included leading global medical affairs and clinical research, and product management of AI-powered medical device software. She currently works as the Strategic Partnerships Manager at the Institute of Environmental Science and Research Ltd.

Ariane is very familiar with many of the challenges faced by the rare disorders community and is privileged to serve on the RDNZ Board, being appointed in 2024. She was diagnosed with an autoimmune condition 6+ years after first presenting to her GP, and also has someone in her whānau living with the rare disorder, Biliary Atresia.